“…Above this dose, the chance of early mortality increases until it reaches 99% above 400 rem with minimal care. The survival rate at this dose level can be almost doubled with intensive medical treatment (e.g., bone marrow transplants), but death is virtually certain above 1000 rem even with intensive medical care (NRC, 1975;Evans et al, 1985;NCRP, 1989). Most thresholds for non-fatal effects, or early morbidities, are organ-based.…”